While mutations in the <i>epsilon-</i>sarcoglycan gene (SGCE) account for most familial cases, heterozygous pathogenic variants in <i>KCTD17</i> and <i>KCNN2</i> have recently been described as novel genetic causes of MDS. This evidence concerns the gene SGCE and myelodysplastic syndrome.